Comparative analysis of radiotherapy and 89Sr radionuclide therapy in the treatment of cervical metastatic cancer pain
10.3969/j.issn.1005-1678.2017.09.194
- VernacularTitle:放射治疗与89Sr核素治疗对椎骨转移癌性疼痛的临床疗效比较分析
- Author:
Qi YANG
;
Jianqiang WANG
;
Fan ZHOU
;
Xueyuan FAN
;
Liqiang ZHONG
;
Yuming JIA
- Keywords:
radiotherapy;
89Sr nuclide;
vertebral metastasis;
cancerous pain;
comparison of effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):436-437
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effect of 89Sr radionuclide therapy and radiotherapy in the treatment of metastatic cancer pain of vertebral column. Methods 80 patients with cancer pain of vertebral metastasis in the second People's hospital of Yibin from April 2015 to April 2017, were randomly divided into the control group treated by radiotherapy treatment (n=40) and the the observation group treated by 89Sr radionuclide therapy(n=40), and the effect of treatment were compared between two groups. Results In the observation group, the total effective rate of pain response in patients with metastatic cancer pain of vertebral column was 85.0％, and the control group was 82.5％. There was no significant difference between two groups. The onset time of treatment in the observation group was (6.5±1.7)d, significantly shorter than that of the control group (12.9±2.6)d, and the difference was statistically significance (P<0.05). Conclusion The application of 89Sr radionuclide therapy in the treatment of vertebral metastatic pain is equivalent to the radiotherapy in improving the pain response, but the efficacy could be achieved in a short period of time, so it is worth popularizing widely in clinical practice.
